APA (7th ed.) Citation

Kyungha Min, Bumjo Oh, Hye Yeon Koo, Yang-Hyun Kim, Ji-Won Lee, Ji-Won Lee, . . . Hyuktae Kwon. (2023). Effect of anti-obesity agent HSG4112 on overweight and obese patients following 12 weeks of oral treatment: A study protocol for a randomised, double-blind, placebo-controlled, parallel-group, phase 2a clinical trial. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Kyungha Min, Bumjo Oh, Hye Yeon Koo, Yang-Hyun Kim, Ji-Won Lee, Ji-Won Lee, Sangsub Lee, Youngah Kim, and Hyuktae Kwon. Effect of Anti-obesity Agent HSG4112 on Overweight and Obese Patients Following 12 Weeks of Oral Treatment: A Study Protocol for a Randomised, Double-blind, Placebo-controlled, Parallel-group, Phase 2a Clinical Trial. Frontiers Media S.A., 2023.

MLA (9th ed.) Citation

Kyungha Min, et al. Effect of Anti-obesity Agent HSG4112 on Overweight and Obese Patients Following 12 Weeks of Oral Treatment: A Study Protocol for a Randomised, Double-blind, Placebo-controlled, Parallel-group, Phase 2a Clinical Trial. Frontiers Media S.A., 2023.